Key points are not available for this paper at this time.
Brazil, the most populous country in Latin America, has a public Unified Health System (SUS) that constitutionally provides free healthcare to over 200 million people. Advanced Therapy Medicinal Products (ATMP) have revolutionized medicine, offering curative treatments for some diseases. The Lancet Regional Health—Americas article “Clinical trials to gene therapy development and production in Brazil: a review” by Saute et al.1 examines the state of gene therapy in Brazil, highlighting the progress made and challenges that remain.
Carvalho et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: